Cargando…
Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre
Background: Phyllodes tumors (PTs) of the breast are rare fibroepithelial tumors that are generally more prone to recurrence. Aims and objectives: This study aimed to assess the clinicopathological features, diagnostic modalities, and therapeutic interventions, along with their respective outcomes,...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221551/ https://www.ncbi.nlm.nih.gov/pubmed/37241036 http://dx.doi.org/10.3390/jpm13050866 |
_version_ | 1785049483477778432 |
---|---|
author | Sain, Baijaeek Gupta, Arnab Ghose, Aruni Halder, Sudip Mukherjee, Vishal Bhattacharya, Samir Mondal, Radha Raman Sen, Aditya Narayan Saha, Bijan Roy, Shravasti Boussios, Stergios |
author_facet | Sain, Baijaeek Gupta, Arnab Ghose, Aruni Halder, Sudip Mukherjee, Vishal Bhattacharya, Samir Mondal, Radha Raman Sen, Aditya Narayan Saha, Bijan Roy, Shravasti Boussios, Stergios |
author_sort | Sain, Baijaeek |
collection | PubMed |
description | Background: Phyllodes tumors (PTs) of the breast are rare fibroepithelial tumors that are generally more prone to recurrence. Aims and objectives: This study aimed to assess the clinicopathological features, diagnostic modalities, and therapeutic interventions, along with their respective outcomes, to identify the factors associated with a recurrence of PTs of the breast. Methodology: A retrospective cohort and observational study was conducted, which entailed analyzing the clinicopathological data of patients who were previously diagnosed or presented with PTs of the breast between 1996 and 2021. Data included the total number of patients diagnosed with PTs of the breast and their ages, tumor grade on initial biopsy, tumor location (left or right breast), tumor size, therapeutic interventions carried out (including surgery—either mastectomy or lumpectomy—and adjuvant radiotherapy), final tumor grade, recurrence status, type of recurrence, and time to recurrence. Results: We analyzed data on a total of 87 patients who were pathologically proven to have PTs, and 46 patients (52.87%) were found to have recurrences. All patients were female, with a mean age at diagnosis of 39 years (range 15–70). Patients aged <40 years had the highest incidence of recurrence, with a rate of 54.35% (n = 25/46), followed by patients aged >40 years, with a rate of recurrence of 45.65% (n = 21/46). A total of 55.4% of patients presented with primary PTs and 44.6% had recurrent PTs at presentation. The average time to local recurrence (LR) from the completion of treatment was 13.8 months, whereas for systemic recurrence (SR), it was 15.29 months. Surgery (mastectomy/lumpectomy) was the major determinant for local recurrence (p < 0.05). Conclusion: Patients who received adjuvant radiotherapy (RT) had a minimal recurrence of PTs. Patients who were found to have a malignant biopsy on initial diagnosis (triple assessment) had a higher incidence of PTs and were more prone to SR than LR. Surgery was a determining factor in the increased rate of LR, with lumpectomy associated with a higher incidence of LR than mastectomy. |
format | Online Article Text |
id | pubmed-10221551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102215512023-05-28 Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre Sain, Baijaeek Gupta, Arnab Ghose, Aruni Halder, Sudip Mukherjee, Vishal Bhattacharya, Samir Mondal, Radha Raman Sen, Aditya Narayan Saha, Bijan Roy, Shravasti Boussios, Stergios J Pers Med Article Background: Phyllodes tumors (PTs) of the breast are rare fibroepithelial tumors that are generally more prone to recurrence. Aims and objectives: This study aimed to assess the clinicopathological features, diagnostic modalities, and therapeutic interventions, along with their respective outcomes, to identify the factors associated with a recurrence of PTs of the breast. Methodology: A retrospective cohort and observational study was conducted, which entailed analyzing the clinicopathological data of patients who were previously diagnosed or presented with PTs of the breast between 1996 and 2021. Data included the total number of patients diagnosed with PTs of the breast and their ages, tumor grade on initial biopsy, tumor location (left or right breast), tumor size, therapeutic interventions carried out (including surgery—either mastectomy or lumpectomy—and adjuvant radiotherapy), final tumor grade, recurrence status, type of recurrence, and time to recurrence. Results: We analyzed data on a total of 87 patients who were pathologically proven to have PTs, and 46 patients (52.87%) were found to have recurrences. All patients were female, with a mean age at diagnosis of 39 years (range 15–70). Patients aged <40 years had the highest incidence of recurrence, with a rate of 54.35% (n = 25/46), followed by patients aged >40 years, with a rate of recurrence of 45.65% (n = 21/46). A total of 55.4% of patients presented with primary PTs and 44.6% had recurrent PTs at presentation. The average time to local recurrence (LR) from the completion of treatment was 13.8 months, whereas for systemic recurrence (SR), it was 15.29 months. Surgery (mastectomy/lumpectomy) was the major determinant for local recurrence (p < 0.05). Conclusion: Patients who received adjuvant radiotherapy (RT) had a minimal recurrence of PTs. Patients who were found to have a malignant biopsy on initial diagnosis (triple assessment) had a higher incidence of PTs and were more prone to SR than LR. Surgery was a determining factor in the increased rate of LR, with lumpectomy associated with a higher incidence of LR than mastectomy. MDPI 2023-05-21 /pmc/articles/PMC10221551/ /pubmed/37241036 http://dx.doi.org/10.3390/jpm13050866 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sain, Baijaeek Gupta, Arnab Ghose, Aruni Halder, Sudip Mukherjee, Vishal Bhattacharya, Samir Mondal, Radha Raman Sen, Aditya Narayan Saha, Bijan Roy, Shravasti Boussios, Stergios Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title | Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title_full | Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title_fullStr | Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title_full_unstemmed | Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title_short | Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre |
title_sort | clinico-pathological factors determining recurrence of phyllodes tumors of the breast: the 25-year experience at a tertiary cancer centre |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221551/ https://www.ncbi.nlm.nih.gov/pubmed/37241036 http://dx.doi.org/10.3390/jpm13050866 |
work_keys_str_mv | AT sainbaijaeek clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT guptaarnab clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT ghosearuni clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT haldersudip clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT mukherjeevishal clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT bhattacharyasamir clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT mondalradharaman clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT senadityanarayan clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT sahabijan clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT royshravasti clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre AT boussiosstergios clinicopathologicalfactorsdeterminingrecurrenceofphyllodestumorsofthebreastthe25yearexperienceatatertiarycancercentre |